Src inhibitor compounds for skeletal muscle modulation, methods and uses thereof

A technology of compounds and compositions, applied in the field of novel SRC inhibitor compounds, capable of solving problems such as low regeneration potential of myoblasts

Inactive Publication Date: 2021-03-26
SOC DES PROD NESTLE SA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Previous experimental therapies that have included myoblast transplantation have not been entirely successful because the more committed and differentiated myoblasts have a lower regenerative potential compared to muscle stem cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Src inhibitor compounds for skeletal muscle modulation, methods and uses thereof
  • Src inhibitor compounds for skeletal muscle modulation, methods and uses thereof
  • Src inhibitor compounds for skeletal muscle modulation, methods and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0233] Example 1: Selection of compounds that modulate muscle stem cells

[0234] Selection of human skeletal muscle myoblasts

[0235] The inventors developed a high content screen to test compounds on primary human adult muscle cells in vitro. Human skeletal muscle myoblasts (HSMM) were purchased from Lonza (https: / / bioscience.lonza.com). These cells were isolated from normal donor upper arm or leg muscle tissue and used after a second passage. Several donors were tested to ensure cell viability and purity before selecting the final donors who were a 36-year-old Caucasian female (Donor 8) and a 20-year-old Caucasian female (Donor 4).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to novel SRC inhibitor compounds for improving skeletal muscle regeneration to maintain or increase muscle function and / or muscle mass by modulating muscle stem cells. For example, the present invention is useful for subjects to promote muscle repair and / or subjects suffering from precachexia, cachexia, sarcopenia, myopathy, dystrophy and / or recovery after muscle injury or surgery.

Description

technical field [0001] The present invention relates to novel SRC inhibitor compounds for use in improving skeletal muscle regeneration by modulating muscle stem cells to maintain or increase muscle function and / or muscle mass. For example, the present invention may be used in individuals who want to promote muscle repair and / or in individuals suffering from precachexia, cachexia, sarcopenia, myopathy, malnutrition, and / or recovery after muscle injury or surgery. Background technique [0002] Skeletal muscle regeneration is an important mechanism for repairing and maintaining muscle mass and function throughout the lifespan. Skeletal muscle regeneration primarily requires the involvement of myogenic progenitor cells, called muscle stem cells or satellite cells. [0003] Nonproliferative quiescent satellite cells adjacent to resting skeletal muscle can be identified by their variable location between the sarcolemma and basal lamina, high nuclear to cytoplasmic volume ratio, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/519A61P21/00A61P35/00A61K45/00A01K67/00A23K20/174A23K20/116A23K20/158A23K50/10A23K50/20A23K50/30A23K50/40
CPCA23K20/116A23K20/158A23K20/174A23K50/10A23K50/20A23K50/30A23K50/40A61K31/519A61K45/00A61P21/00A61P35/00A61K2300/00C07D487/04
Inventor D·M·巴伦J·费奇S·卡拉兹J·米肖Y·拉蒂诺P·斯图尔萨茨
Owner SOC DES PROD NESTLE SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products